# The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

> **NCT05386186** · PHASE4 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 192 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Severe Insulin Deficient Diabetes

## Interventions

- **DRUG:** Glimepiride
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT05386186
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2022-05-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05386186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05386186, "The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05386186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*